Caricamento...
Different dosage schedules for reducing cardiotoxicity in people with cancer receiving anthracycline chemotherapy
BACKGROUND: This review update has been managed by both the Childhood Cancer and Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Groups. The use of anthracycline chemotherapy is limited by the occurrence of cardiotoxicity. To prevent this cardiotoxicity, different anthracycline dosage sche...
Salvato in:
| Pubblicato in: | Cochrane Database Syst Rev |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley & Sons, Ltd
2016
|
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6457744/ https://ncbi.nlm.nih.gov/pubmed/26938118 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD005008.pub4 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|